Varicella-zoster virus can cause neurological disease in primary and reactivated latent forms, with a wide spectrum of disorders throughout a person's lifetime. 35-year-old male with AIDS; histoplasmosis; mild, intermittent asthma; and hypertension presented to hospital with left-sided weakness and slurred speech. Exam showed left hemiparesis with left upper motor neurons facial palsy and dysarthria. Acute right basal ganglia infarct was detected in head CT without contrast. A subsequent MRI showed acute non-hemorrhagic infarct, right basal ganglia; fusiform dilatation, and proximal right middle cerebral artery. A CT angiogram of the bilateral carotid arteries revealed occlusion of the right anterior cerebral artery with conical dilatation at the origin; significant stenosis, and dilatation of the right middle cerebral artery. These findings were consistent with vasculitis. Patient was successfully treated with IV acyclovir. Rapid diagnosis of VZV vasculopathy is important because it is a treatable cause of stroke. Mortality rate is 25% without treatment.
Introduction
Varicella-zoster virus (VZV) can cause neurological disease in primary and reactivated latent forms, with a wide spectrum of disorders throughout a person's lifetime. 1, 2 Very few cases of VZV vasculitis have been reported 3 ; a standard for optimal treatment has not been established. Our patient twice presented with stroke; 1 episode, which we will describe here, fitting with VZV vasculopathy diagnostic criteria.
Case
A 35-year-old male with AIDS and no prior history of stroke; histoplasmosis; mild, intermittent asthma; and hypertension presented to the hospital with left-sided body weakness and slurred speech for 1 day. The patient started on highly active antiretroviral therapy 9 years prior and his current regimen of Atripla (efavirenz, tenofovir, and emtricitabine) 2 years ago. Additional at-home medications included albuterol inhaler and hydrochlorothiazide. Physical examinatiom showed left hemiparesis with left upper motor neurons facial palsy and dysarthria.
An acute right basal ganglia infarct was detected in a head computerized tomography (CT) without contrast. A subsequent magnetic resonance imaging (MRI) of the head showed acute nonhemorrhagic infarct, right basal ganglia; fusiform dilatation, and proximal right middle cerebral artery. A CT angiogram of the bilateral carotid arteries revealed occlusion of the right anterior cerebral artery with conical dilatation at the origin, significant stenosis, and dilatation of the right middle cerebral artery ( Figure 1 ). These findings were consistent with vasculitis, but vasculitis laboratory workup results were negative.
Cerebrospinal fluid analysis revealed a white blood cell (WBC) of 55 (100% monocytes), protein of 32 mg/dL, and a glucose of 62 mg/dL. The polymerase chain reaction (PCR) was positive for VZV DNA. At the time of the diagnosis of stroke, the patient had an absolute CD4 count of 44 cells/mm 3 , ultrasensitive HIV RNA of 31 527 copies/mL, and a HIV-1 RNA (log10) of 4.5.
The patient was successfully treated with intravenous (IV) acyclovir at 10 mg/kg every 8 hours for 10 days. Except for minimal residual weakness, the patient continued to do well 8 months later on oral acyclovir.
Discussion
Human neurotropic virus VZV belongs to the herpesviridae family of DNA viruses. Primary infection causes varicella (chickenpox). VZV establishes latent infection mainly in the trigeminal and dorsal root ganglia. Neurological complications from VZV reactivation include herpes zoster (shingles), postherpetic neuralgia, vasculopathy, myelitis, zoster sine herpete, and necrotizing retinitis. 4 VZV vasculopathy results from VZV-infected blood vessels. After ganglial reactivation, the virus spreads transaxonally to the vessel wall, causing inflammation and subsequent arterial thrombosis and occlusion. In addition to thrombosis, VZV vasculopathy can also cause arterial ectasia, cervical artery dissection, aneurysm, and subarachnoid hemorrhage. 5 Autopsy findings include arterial inflammation-multinucleated giant cells, Cowdry type A inclusion bodies, VZV antigens, and VZV nucleic acids. VZV infection involves large and small arteries. Large vessel unifocal vasculopathy is usually seen in immunocompetent hosts, while small vessel multifocal vasculopathy is seen in immunocompromised patients. 6 Manifestations of VZV include rash, MRI/CT findings of cerebral hemorrhage/ischemia, angiography showing aneurysm, and cerebrospinal fluid (CSF) pleocytosis. Virological confirmation requires labs to detect VZV DNA or anti-VZV immunoglobulin G (IgG); VZV is excluded only if both are negative. 3 Rapid diagnosis of VZV vasculopathy is important because it is a treatable cause of stroke. Mortality rate is 25% without treatment. 1 Based on clinical experience, treatment includes IV acyclovir with or without steroids. 
